Hematological diseases serve as a vital "experimental field" for the development of new drugs and treatment methods. Many innovative therapies are rooted in hematology research, with advanced technologies such as tumor-targeted therapy, cell immunotherapy, and gene therapy all originating from the treatment of hematological conditions. The Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS), was the first specialty hospital in China dedicated to both patient care and scientific research in hematology, serving as an educational center for hematologists across the country. Over the years, IHCAMS has conducted the most clinical trials of new drugs for hematological diseases in China. Notably, there are many ongoing trials on cell and gene therapy products at our hospital. The first CAR-T product for refractory adult B-ALL developed at IHCAMS was approved for the market in China in 2023. With the official inauguration of the new medical center at IHCAMS in September 2023, it has become the largest treatment center for blood diseases in the world, featuring 14 clinical centers and 1,500 beds covering both pediatric and adult hematology. IHCAMS has consistently ranked as the top specialty hospital for both clinical care and scientific impact in hematology in China for the past 14 and 11 years, respectively. The International Workshop on Cell Therapy of Blood Diseases hosted by IHCAMS and supported by the Ministry of Science and Technology of the People's Republic of China, aims to provide fundamental, clinical, and translational courses for junior researchers and physicians across the Belt and Road countries. The traineeship offers a two-week program covering courses in cellular therapy and gene therapy for hematologic diseases such as hematologic malignancies and thalassemia, immunotherapies for hematologic and other diseases, and spatial-temporal omics in blood disease research.
Guideline for Application:
- Qualifications for Application: Researchers or physicians holding either a Ph.D. or an M.D. degree who are currently employed by professional institutions in the Belt and Road countries.
- Application Due Date: Monday, May 12, 2025, 11:59 p.m. GMT
- List of Notice of Admission: May 30, 2025
- Program Start Date: August 17, 2025
- Language: English
- Supporting Documents: 1. Complete personal CV; 2. Proof of professional qualifications; 3. Photocopy of travel documents; 4. Supporting letter from the employer. Please include all the required documents and email to: xcwang@ihcams.ac.cn.
- Fees: The workshop will cover training expenses and accommodation for trainees during their stay in Tianjin, China, from August 17 to September 1, 2025. Please note that trainees will be responsible for their travel expenses and any costs NOT mentioned above.
Program:
Date
Session Topic
Speaker
Venue
Sun, Aug 17, 2025
All-day: Registration
Hotel
Mon, Aug 18, 2025
Morning:
Opening Ceremony
Cheng Tao
Tuanbo Campus
Stem Cell Basic Research and Clinical
Applications
Cheng Tao
Tuanbo Campus
Afternoon:
Overview of Immunotherapy for
Hematologic Malignancies
Wang Jianxiang
Tuanbo Campus
Tue, Aug 19, 2025
Morning:
Overview of Hematopoietic Stem Cell
Transplantation (HSCT)
TBD
Tuanbo Campus
Stem Cell Mobilization &
Collection
TBD
Tuanbo Campus
Afternoon:
Tour of Apheresis Unit (Transfusion
Center)
Li Qiang
Tuanbo Campus
Wed, Aug 20, 2025
Morning:
Management of Transplant Complications
Feng Sizhou
Tuanbo Campus
Prevention and Treatment of
Post-Transplant Relapse
Pang Aiming
Tuanbo Campus
Afternoon:
Tour of Cord Blood Bank and Transplant
Center
Huayuan Campus
Thu, Aug 21, 2025
Morning:
Tour of Cell Ecology Haihe Laboratory
Zhang Yingchi
Haihe Lab
Afternoon:
Cell Preparation and Quality Control
in GMP Facilities
TBD
Haihe Lab
Fri, Aug 22, 2025
Morning:
Clinical Applications of Mesenchymal
Stem Cells
TBD
Tuanbo Campus
Overview of iPS Cell Research
TBD
Tuanbo Campus
Afternoon:
CAR T Applications in Autoimmunity and
Transplantation
VJ
Tuanbo Campus
Sat-Sun, Aug 23-24
Weekend Break
Mon, Aug 25, 2025
Morning:
Advances in Immunotherapy for Acute
Lymphoblastic Leukemia
TBD
Tuanbo Campus
Advances in Immunotherapy for Multiple
Myeloma
TBD
Tuanbo Campus
Afternoon:
Advances in Immunotherapy for Lymphoma
TBD
Tuanbo Campus
Tue, Aug 26, 2025
Morning:
CAR-T Cell Manufacturing
Wang Yongzeng (Juventas Cell Therapy
Ltd.)
Tuanbo Campus
Afternoon:
Visit to Juventas Cell Therapy Ltd.
Juventas Cell Therapy Ltd.
Juventas Cell Therapy Ltd.
Wed, Aug 27, 2025
Morning:
AAV Vector-Based Gene Therapy for
Hemophilia B
Xiao Xiao
(Belief Biomed)
Tuanbo Campus
Case Study
TBD
Tuanbo Campus
Afternoon:
Preparation of AAV Gene Therapy
Zheng Jing
Tuanbo Campus
Thu, Aug 28, 2025
Morning:
Gene Therapy for Thalassemia
Kanglin Biotec
Tuanbo Campus
CAR T-Cell Therapy for Autoimmune
Hemolytic Anemia (AIHA)
Li Ruonan
Tuanbo Campus
Afternoon:
Group Discussion
Tuanbo Campus
Fri, Aug 29, 2025
Morning:
Accelerating Translational Research:
From Bench to Industry
Zhang Yu
Haiguang Campus
Group Discussion
Afternoon:
Tour of Hospital History Museum
Tour of Diagnostics Platform
Organizing Committee/ Pathology Center
Haiguang Campus
Sat-Sun, Aug 30-31
Weekend Break
Mon, Sep 1, 2025
Afternoon:
Closing Ceremony
Haiguang Campus
Venue:
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tuanbo Campus
28 Tuanbo Road, Jinghai, Tianjin, China
Contact:
Should you have any questions, please feel free to contact the Dr. Xiaochen Wang, by phone (86-22-23909681) or via email: xcwang@ihcams.ac.cn.